Literature DB >> 16567534

Survival benefits of intensive insulin therapy in critical illness: impact of maintaining normoglycemia versus glycemia-independent actions of insulin.

Björn Ellger1, Yves Debaveye, Ilse Vanhorebeek, Lies Langouche, Annapaula Giulietti, Evelyne Van Etten, Paul Herijgers, Chantal Mathieu, Greet Van den Berghe.   

Abstract

Tight blood glucose control with insulin reduces morbidity and mortality of critically ill patients. However, the relative impact of maintaining normoglycemia and of glycemia-independent actions of insulin remains unknown. We therefore independently manipulated blood glucose and plasma insulin levels in burn-injured, parentally fed rabbits over 7 days to obtain four study groups: two normoglycemic groups with either normal or elevated insulin levels and two hyperglycemic groups with either normal or elevated insulin levels. We studied the relative impact of glycemia and glycemia-independent effects of insulin on survival; myocardial contractility in an open chest preparation; endothelial function in isolated aortic rings; and liver, kidney, and leukocyte function in a rabbit model of critical illness. Mortality was significantly lower in the two normoglycemic groups independent of insulin levels. Maintaining normoglycemia, independent of insulin levels, prevented endothelial dysfunction as well as liver and kidney injury. To increase myocardial systolic function, elevated insulin levels and prevention of hyperglycemia were required concomitantly. Leukocyte dysfunction was present in the two hyperglycemic groups, which could in part be rescued by insulin. The results suggest that the observed benefits of intensive insulin therapy required mainly maintenance of normoglycemia; whereas glycemia-independent actions of insulin exerted only minor, organ-specific impact.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16567534     DOI: 10.2337/diabetes.55.04.06.db05-1434

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


  45 in total

1.  Intensive insulin therapy in severely burned pediatric patients: a prospective randomized trial.

Authors:  Marc G Jeschke; Gabriela A Kulp; Robert Kraft; Celeste C Finnerty; Ron Mlcak; Jong O Lee; David N Herndon
Journal:  Am J Respir Crit Care Med       Date:  2010-04-15       Impact factor: 21.405

Review 2.  Intensive insulin therapy in the ICU--reconciling the evidence.

Authors:  Greet Van den Berghe
Journal:  Nat Rev Endocrinol       Date:  2012-02-07       Impact factor: 43.330

3.  Insulin therapy in the intensive care unit should be targeted to maintain blood glucose between 4.4 mmol/l and 6.1 mmol/l.

Authors:  G Van den Berghe
Journal:  Diabetologia       Date:  2007-11-27       Impact factor: 10.122

4.  Early hyperglycemia and intravenous insulin-the rationale and management of hyperglycemia for spontaneous intracerebral hemorrhage patients: is time for change?

Authors:  Daniel A Godoy; Gustavo R Piñero; Silvana Svampa; Francesca Papa; Mario Di Napoli
Journal:  Neurocrit Care       Date:  2009       Impact factor: 3.210

5.  Mesenchymal stem cells decrease splenocytes apoptosis in a sepsis experimental model.

Authors:  Leonardo Pedrazza; Adroaldo Lunardelli; Carolina Luft; Carolina Uribe Cruz; Fernanda Cristina de Mesquita; Shanna Bitencourt; Fernanda Bordignon Nunes; Jarbas Rodrigues de Oliveira
Journal:  Inflamm Res       Date:  2014-06-03       Impact factor: 4.575

6.  Blood glucose control in the ICU: don't throw out the baby with the bathwater!

Authors:  Jan Gunst; Greet Van den Berghe
Journal:  Intensive Care Med       Date:  2016-05-09       Impact factor: 17.440

7.  Increased blood flow by insulin infusion targeting normoglycemia in patients with severe sepsis: friend or foe?

Authors:  Greet Van den Berghe
Journal:  Crit Care       Date:  2010-02-16       Impact factor: 9.097

8.  Acute hyperglycemia worsens hepatic ischemia/reperfusion injury in rats.

Authors:  Matthias Behrends; Graciela Martinez-Palli; Claus U Niemann; Sara Cohen; Rageshree Ramachandran; Ryutaro Hirose
Journal:  J Gastrointest Surg       Date:  2009-12-09       Impact factor: 3.452

Review 9.  Insulin resistance postburn: underlying mechanisms and current therapeutic strategies.

Authors:  Gerd G Gauglitz; David N Herndon; Marc G Jeschke
Journal:  J Burn Care Res       Date:  2008 Sep-Oct       Impact factor: 1.845

10.  Treatment with insulin inhibits poly(ADP-ribose)polymerase activation in a rat model of endotoxemia.

Authors:  Eszter M Horváth; Rita Benko; Domonkos Gero; Levente Kiss; Csaba Szabó
Journal:  Life Sci       Date:  2007-11-21       Impact factor: 5.037

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.